A phase 3 trial in colorectal cancer, run by University Hospital, Basel, Switzerland, now recruiting.
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance is a phase 3, randomised interventional study registered as NCT06936774 by University Hospital, Basel, Switzerland, with a registry enrolment figure of 140 participants, started 2025-12-01 and due to reach its primary completion in 2028-05-01. Interventions recorded: Intensified follow-up program. Conditions listed: LARS - Low Anterior Resection Syndrome; Rectal Cancer Surgery; Rectal Cancer; Quality of Life (QOL). Primary outcome: Improvement of the LARS score after 13 months. Colorectal eligibility wording from the registry: "* patients with rectal cancer in the middle and lower third of the rectum in stages I to IV who underwent LAR with TME and protective ileostomy". Sites: Switzerland. No results are recorded here; the registry entry is the source.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.